Search

Author/Creator Pomerantz, Mark M.

1. A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration‐resistant prostate cancer. Issue 4 (14th November 2018)

Authors:
McKay, Rana R.; Werner, Lillian; Jacobus, Susanna J.; Jones, Alexandra; Mostaghel, Elahe A.; Marck, Brett T.; Choudhury, Atish D.; Pomerantz, Mark M.; Sweeney, Christopher J.; Slovin, Susan F.; Morris, Michael J.; Kantoff, Philip W.; Taplin, Mary‐Ellen
Journal:
Cancer
Issue:
Volume 125:Issue 4(2019)
Page Start:
524
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Association between very small tumour size and increased cancer‐specific mortality after radical prostatectomy in lymph node‐positive prostate cancer. (31st August 2015)

Authors:
Muralidhar, Vinayak; Mahal, Brandon A.; Nezolosky, Michelle D.; Beard, Clair J.; Feng, Felix Y.; Martin, Neil E.; Efstathiou, Jason A.; Choueiri, Toni K.; Pomerantz, Mark M.; Sweeney, Christopher J.; Trinh, Quoc‐Dien; Vander Heiden, Matthew G.; Nguyen, Paul L.
Journal:
BJU international
Issue:
Volume 118:Number 2(2016:Jul.)
Page Start:
279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The association between germline BRCA2 variants and sensitivity to platinum‐based chemotherapy among men with metastatic prostate cancer. Issue 18 (13th June 2017)

Authors:
Pomerantz, Mark M.; Spisák, Sandor; Jia, Li; Cronin, Angel M.; Csabai, Istvan; Ledet, Elisa; Sartor, A. Oliver; Rainville, Irene; O'Connor, Edward P.; Herbert, Zachary T.; Szállási, Zoltan; Oh, William K.; Kantoff, Philip W.; Garber, Judy E.; Schrag, Deborah; Kibel, Adam S.; Freedman, Matthew L.
Journal:
Cancer
Issue:
Volume 123:Issue 18(2017)
Page Start:
3532
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗